Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05669898
Other study ID # TPEVGH IRB No.: 2018-08-007A
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 21, 2019
Est. completion date June 30, 2023

Study information

Verified date March 2023
Source Taipei Veterans General Hospital, Taiwan
Contact Chun-Sung Sung, MD, PhD
Phone 886-2-28757549
Email cssung@vghtpe.gov.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Multimodal analgesia (MMA) has been endorsed to improve postoperative analgesia and functional activity after surgery, and integrating regional analgesia to reduce the consumption of opioid has also been used in postoperative pain management. The investigator try to find a better combination of MMA for postoperative analgesia and functional recovery for patients receiving TKA in Taiwan, therefore the effect of single-injection and continuous infusion of peripheral nerve block is compared in patient undergoing unilateral TKA. The investigators hypothesize that continuous adductor canal infusion is as effective as single-injection adductor canal block for postoperative pain relief under intravenous PCA after TKA surgery. Based on that, the investigators conduct this prospective, randomized controlled trial to examine our hypothesis.


Description:

The study compares the effect of two multimodal analgesia protocols, the one integrating IVPCA morphine with single-injection adductor canal block and the other integrating continuous adductor canal infusion with timely administered intravenous tenoxicam, on postoperative analgesia and functional activity after TKA. To assess the outcome of both modalities, The investigators can have more comparative result of pain score and other functional parameters like range of motion of knee joint and muscle strength. Based on that, the investigators try to find a better multimodal analgesic approach for postoperative analgesia and functional recovery for patients receiving TKA in Taiwan. The investigators hypothesize that multimodal analgesia using continuous adductor canal infusion and intravenous tenoxicam are as effective as another modality using IVPCA and single-injection adductor canal block for postoperative pain relief after TKA surgery. However, continuous adductor canal infusion integrated with intravenous tenoxicam might reduce the occurrence of opioid-related side effect and enhance the functional recovery. Based on that, the investigators conduct this prospective, randomized controlled trial to examine our hypothesis.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date June 30, 2023
Est. primary completion date May 31, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria - Clinical diagnosis of knee osteoarthritis - Must be aged between 20 to 90 years old - Must be scheduled for unilateral total knee arthroplasty surgery - Must agree to enroll into the clinical trial and have signed the written informed consent Exclusion Criteria: - American Society of Anesthesiologists physical status class IV-V - Elevated liver enzymes or liver failure - Renal dysfunction (serum creatinine level = 1.5 mg/dL) - Cardiac failure - Organ transplantation recipient - Stroke - Major neurological deficit with lower extremity muscle weakness - Sensory and motor disorders in lower limb - Coagulopathy or thrombocytopenia - Previous drug dependency - Patients who used illicit drugs within six months - Chronic use of opioids - Allergy to local anesthetics and drug used in experiment - Inability to walk independently - Inability to comprehend pain assessment - Refusal for implanting a continuous peripheral nerve catheter - Refusal for enrolling in study

Study Design


Intervention

Behavioral:
Pain scores (numerical rating scale at rest and motion): will be assessed with numerical rating scale at both rest and motion on both knees.
Pain scores will be assessed with numerical rating scale at both rest and motion on both knees.
Other:
Brief Pain Inventory (Short Form), WOMAC Osteoarthritis index, and Lower extremity functional scale
For the functional assessment both before and after TKA surgery.
Behavioral:
Rehabilitation physiotherapy
Rehabilitation physiotherapy will be assessed with knee range of motion (both active and maximal passive), muscle power at abduction and adduction, single leg stance test, six-minute walk test for assessment of the functional recovery of both knees.

Locations

Country Name City State
Taiwan Taipei Veterans General Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Veterans General Hospital, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Baseline (day of admission)
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 2 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 8 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 24 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 36 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 48 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 60 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Hour 72 after surgery
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. 1 day of discharge
Primary Change in Pain scores at rest and motion Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable. Month 3 after surgery
Secondary Rehabilitation physiotherapy: Knee flexion angle Maximal range of motion at both continuous passive motion and active motion will be assessed with protractor (degrees) Baseline (day of admission)
Secondary Rehabilitation physiotherapy: Knee flexion angle Maximal range of motion at both continuous passive motion and active motion will be assessed with protractor (degrees) Hour 24 after surgery
Secondary Rehabilitation physiotherapy: Knee flexion angle Maximal range of motion at both continuous passive motion and active motion will be assessed with protractor (degrees) Hour 72 after surgery
Secondary Rehabilitation physiotherapy: Knee flexion angle Maximal range of motion at both continuous passive motion and active motion will be assessed with protractor (degrees) 1 Day of discharge
Secondary Rehabilitation physiotherapy: Knee flexion angle Maximal range of motion at both continuous passive motion and active motion will be assessed with protractor (degrees) Month 3 after surgery
Secondary Rehabilitation physiotherapy: knee muscle strength Muscle power of the surgical knee at abduction and adduction accessed by JTech Commander Echo Manual Muscle Tester Baseline (day of admission)
Secondary Rehabilitation physiotherapy: knee muscle strength Muscle power of the surgical knee at abduction and adduction accessed by JTech Commander Echo Manual Muscle Tester Hour 24 after surgery
Secondary Rehabilitation physiotherapy: knee muscle strength Muscle power of the surgical knee at abduction and adduction accessed by JTech Commander Echo Manual Muscle Tester Hour 72 after surgery
Secondary Rehabilitation physiotherapy: knee muscle strength Muscle power of the surgical knee at abduction and adduction accessed by JTech Commander Echo Manual Muscle Tester 1 day of discharge
Secondary Rehabilitation physiotherapy: knee muscle strength Muscle power of the surgical knee at abduction and adduction accessed by JTech Commander Echo Manual Muscle Tester Month 3 after surgery
Secondary Rehabilitation physiotherapy: Six minute walk test To assess the walk ability (6-minute walk distance) before and after surgery (meters) Baseline (day of admission)
Secondary Rehabilitation physiotherapy: Six minute walk test To assess the walk ability (6-minute walk distance) before and after surgery (meters) Hour 24 after surgery
Secondary Rehabilitation physiotherapy: Six minute walk test To assess the walk ability (6-minute walk distance) before and after surgery (meters) Hour 72 after surgery
Secondary Rehabilitation physiotherapy: Six minute walk test To assess the walk ability (6-minute walk distance) before and after surgery (meters) 1 date of discharge
Secondary Rehabilitation physiotherapy: Six minute walk test To assess the walk ability (6-minute walk distance) before and after surgery (meters) Month 3 after surgery
Secondary Rehabilitation physiotherapy: Single leg stance test To assess the stance ability and static postural and balance control on one leg without help either with eyes opened or closed before and after TKA surgery (assessed as seconds) Baseline (day of admission)
Secondary Rehabilitation physiotherapy: Single leg stance test To assess the stance ability and static postural and balance control on one leg without help either with eyes opened or closed before and after TKA surgery (assessed as seconds) Hour 24 after surgery
Secondary Rehabilitation physiotherapy: Single leg stance test To assess the stance ability and static postural and balance control on one leg without help either with eyes opened or closed before and after TKA surgery (assessed as seconds) Hour 72 after surgery
Secondary Rehabilitation physiotherapy: Single leg stance test To assess the stance ability and static postural and balance control on one leg without help either with eyes opened or closed before and after TKA surgery (assessed as seconds) 1 day of discharge
Secondary Rehabilitation physiotherapy: Single leg stance test To assess the stance ability and static postural and balance control on one leg without help either with eyes opened or closed before and after TKA surgery (assessed as seconds) Month 3 after surgery
Secondary Functional questionnaire: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Osteoarthritis Index For functional pain assessment Baseline (day of admission)
Secondary Functional questionnaire: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Osteoarthritis Index For functional pain assessment 1 day of discharge
Secondary Functional questionnaire: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Osteoarthritis Index For functional pain assessment Month 3 after surgery
Secondary Functional questionnaire: Brief pain inventory (BPI) short form For functional pain assessment Baseline (day of admission)
Secondary Functional questionnaire: Brief pain inventory (BPI) short form For functional pain assessment 1 day of discharge
Secondary Functional questionnaire: Brief pain inventory (BPI) short form For functional pain assessment Month 3 after surgery
Secondary Functional questionnaire: Lower extremity functional scale Scoring scales from 0 to 80 with the maximum score being 80 and the lower score meaning the the greater disability. Baseline (day of admission)
Secondary Functional questionnaire: Lower extremity functional scale Scoring scales from 0 to 80 with the maximum score being 80 and the lower score meaning the the greater disability. 1 date of discharge
Secondary Functional questionnaire: Lower extremity functional scale Scoring scales from 0 to 80 with the maximum score being 80 and the lower score meaning the the greater disability. Month 3 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Baseline (day of admission)
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 2 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 8 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 24 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 36 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 48 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 60 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Hour 72 after surgery
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia 1 day of discharge
Secondary Adverse events Adverse events will be assessed with items including nausea, vomiting, somnolence, dizziness, urinary retention, skin itch, respiratory depression, and lower limb weakness, numbness, and allodynia Month 3 after surgery
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2